HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A founder COL17A1 splice site mutation leading to generalized atrophic benign epidermolysis bullosa in an extended inbred Palestinian family from Israel.

AbstractPURPOSE:
Generalized atrophic benign epidermolysis bullosa is a nonlethal form of junctional EB with an autosomal recessive inheritance. There is generalized cutaneous blister formation at sites of trauma, atrophic alopecia affecting scalp, eyelash and eyebrow, dystrophic nail changes, and tooth abnormalities. In this study, we have studied a five-generation Palestinian family affected with generalized atrophic benign epidermolysis bullosa.
METHODS:
We have performed linkage analysis to genes that are mutated in generalized atrophic benign epidermolysis bullosa, followed by direct sequencing of patient genomic DNA.
RESULTS:
We have shown that the disease is caused by a newly detected homozygous donor splice site mutation, IVS51+1G>A, in the type XVII collagen gene, COL17A1.
CONCLUSION:
The effect of a founder mutation introduced 3 to 4 generations before a disease appearance is demonstrated in this inbred family.
AuthorsNeil Vincent Whittock, Carron Sher, Isaac Gold, Vitalia Libman, Orit Reish
JournalGenetics in medicine : official journal of the American College of Medical Genetics (Genet Med) 2003 Nov-Dec Vol. 5 Issue 6 Pg. 435-9 ISSN: 1098-3600 [Print] United States
PMID14614394 (Publication Type: Journal Article)
Chemical References
  • Autoantigens
  • Carrier Proteins
  • Cytoskeletal Proteins
  • DNA Primers
  • DST protein, human
  • Dystonin
  • Nerve Tissue Proteins
  • Non-Fibrillar Collagens
  • collagen type XVII
  • Collagen
Topics
  • Autoantigens (genetics)
  • Carrier Proteins
  • Collagen (genetics)
  • Consanguinity
  • Cytoskeletal Proteins
  • DNA Primers
  • Dystonin
  • Epidermolysis Bullosa, Junctional (genetics)
  • Genetic Linkage (genetics)
  • Humans
  • Microsatellite Repeats (genetics)
  • Mutation (genetics)
  • Nerve Tissue Proteins
  • Non-Fibrillar Collagens
  • Pedigree
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: